News

A powerful immune-suppressing molecule produced by the body may hold the key to better treatments for autoimmune and inflammatory diseases, as well as for some cancers, according to a study by researchers at Weill Cornell Medicine and the University of Perugia.

Awards, honors, prizes and achievements for the month of July.

A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.

NewYork-Presbyterian Hospital is ranked No. 1 in New York and No. 7 in the nation by U.S. News & World Report. This is the 21st consecutive year NewYork-Presbyterian Hospital is the top-ranked hospital in New York.

Five Weill Cornell Medicine instructors and junior faculty seeking to pursue independent research careers have received 2021 JumpStart Career Development awards.

Researchers at Weill Cornell Medicine have identified a population of neurons that drive animal brains to initiate actions without prompting from an external stimulus such as food or prey.

The specialized endothelial cells that line the blood vessels in the lung may hold the key to treating the common and often-fatal lung disease emphysema, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Weill Cornell Medicine’s Office of Diversity and Inclusion has been recognized as a Diversity Champion by Crain’s New York Business as part of its first annual Excellence in Diversity and Inclusion Awards, announced July 15.

Despite overwhelming evidence that the benefits of the COVID-19 vaccine outweigh the risks, and that the chances of dying from the coronavirus far exceed those of having an adverse reaction to the shot, reports of rare, (fewer than one in a million) post-vaccine blood clots may have you reconsidering vaccination.

Treatment with a ready-made preparation of human immune cells helps prevent infections in people whose immune systems are temporarily weakened by leukemia treatment.

Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, and Dr. Keith LaScalea, an associate professor of clinical medicine, have been selected for the Crain’s 2021 Notable in Health Care in New York City list.

Growth impairment, a common complication of Crohn’s disease in children, occurs more often in males than females, but the reasons are unclear. Now, a physician-scientist from Weill Cornell Medicine and NewYork-Presbyterian and colleagues at eight other centers have found that factors associated with statural growth differ by sex.

The pandemic is taking a toll on mental health. Fear of illness, as well as loss of income, housing, or schooling have left many people anxious, lonely, and depressed. The toll may be especially great among BIPOC (Black, Indigenous, People of Color) communities, where social and economic disenfranchisement and health and healthcare disparities contribute to higher levels of anxiety, depression, suicidal tendencies, post-traumatic stress, and other mental health disorders. 

The spread of the Delta variant has put countries around the world on high alert. Dr. Roy M. Gulick, chief of the Division of Infectious Diseases at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, and professor of medicine at Weill Cornell Medicine, answers questions about the new threat.

Black patients who have chronic liver failure, also known as end stage liver disease (ESLD), are less likely to be placed on a waiting list for a life-saving liver transplant than other racial and ethnic groups, according to a study of national databases by investigators at Weill Cornell Medicine, NewYork-Presbyterian and Columbia University Vagelos College of Physicians and Surgeons.

The genetic changes that underlie an especially lethal type of prostate cancer have been revealed in a new study by investigators at Weill Cornell Medicine. Learning more about what causes this type of cancer, called neuroendocrine prostate cancer (NEPC), could lead to new approaches for treating it.

Awards, honors, prizes and achievements for the month of June.

A protein called Them1 prevents fat burning in cells by blocking access to the fuel source, according to preclinical research by Weill Cornell Medicine, NewYork-Presbyterian and Harvard Medical School/Beth Israel Deaconess Medical Center investigators.

C2i Genomics, the spinout company to commercialize a super-sensitive cancer blood test developed by scientists at the New York Genome Center (NYGC) and Weill Cornell Medicine, has been named a finalist for The Spinoff Prize 2021. The announcement of this news and a profile of C2i Genomics was published in Nature today.

Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, has been named to Modern Healthcare’s 50 Most Influential Clinical Executives list.